Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. - Baselga,J.; Norton,L.; Albanell,J.; Kim,Y.M.; Mendelsohn,J. (Cancer Res, 1998)